Title: | Chinese expert consensus on off-label drug list (Pediatrics 2024 version) |
Edition: | Updated |
Classification: | Experts consensus |
Field: | Treatment |
Countries and regions: | China |
Guidelines users: | 医生、护士、药师 |
Evidence classification method: | The Thomson classification system standard of Micromedex and reference to other authoritative guidelines and consensus grading standards |
Development unit: | Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University、Shenzhen Children's Hospital、Hospital Pharmacy Committee of Guangdong Pharmaceutical Society、 Pediatric Clinical Rational Drug Use Expert Committee of Guangdong Pharmaceutical Society |
Registration time: | 2024-09-03 |
Registration number: | PREPARE-2024CN389 |
Purpose of the guideline: | The management of pediatric off-label drug use is an important issue faced by all hospitals. In order to assist all medical institutions to develop the catalog of pediatric off-label drug use for reference of all medical institutions. |
Latest registration